Consolidated statements of cash flows - USD ($)
|
12 Months Ended |
Oct. 31, 2021 |
Oct. 31, 2020 |
Oct. 31, 2019 |
| Operating activities |
|
|
|
| Net loss for the year |
$ (226,559,288)
|
$ (9,275,962)
|
$ (4,100,782)
|
| Items not affecting cash |
|
|
|
| Share-based compensation |
3,982,943
|
332,634
|
97,258
|
| Listing fee |
152,719,009
|
0
|
0
|
| Depreciation |
2,899,350
|
1,095,250
|
183,862
|
| Amortization of government grants |
(92,926)
|
(2,226,910)
|
(640,350)
|
| Loss on disposal of assets |
13,399
|
106,946
|
0
|
| Foreign exchange (gain) loss on translation |
677,479
|
(390,901)
|
(33,845)
|
| Fair value loss on financial instruments |
38,254,469
|
84,454
|
0
|
| Share-based professional fees |
0
|
455,055
|
0
|
| Interest and accretion on convertible debt |
1,129,680
|
9,931
|
60,337
|
| Cash flows from (used in) operations before changes in working capital |
(26,975,885)
|
(9,809,503)
|
(4,433,520)
|
| Changes in non-cash working capital items |
|
|
|
| Accounts receivable |
(3,501,401)
|
(538,854)
|
(29,630)
|
| Other receivables |
(654,216)
|
471,304
|
(466,915)
|
| Prepayments and deposits |
(7,990,108)
|
(633,824)
|
(215,537)
|
| Inventory |
(1,017,813)
|
(133,438)
|
(46,556)
|
| Accounts payable and accrued liabilities |
12,262,063
|
3,215,386
|
624,090
|
| Net cash provided by operating activities |
(27,877,360)
|
(7,428,929)
|
(4,568,068)
|
| Investing activity |
|
|
|
| Purchases of plant and equipment |
(18,220,339)
|
(5,107,663)
|
(998,069)
|
| Proceeds from disposal of plant and equipment |
16,866
|
0
|
0
|
| Net cash used in investing activities |
(18,203,473)
|
(5,107,663)
|
(998,069)
|
| Financing activities |
|
|
|
| Proceeds from exercise of stock options |
169,105
|
0
|
0
|
| Proceeds from exercise of warrants |
1,150
|
|
|
| Proceeds from convertible debt |
98,400,263
|
0
|
0
|
| Proceeds from loans payable |
10,091,220
|
2,153,110
|
86,572
|
| Proceeds from government grants |
92,926
|
1,182,599
|
1,697,794
|
| Repayment of lease liabilities |
(884,024)
|
(387,508)
|
0
|
| Repayment of loans payable |
(12,544,339)
|
(12,881)
|
0
|
| Net cash used in financing activities |
642,275,574
|
9,416,701
|
7,164,226
|
| Net change in cash and cash equivalents |
596,194,741
|
(3,119,891)
|
1,598,089
|
| Cash and cash equivalents, beginning of period |
663,557
|
3,783,449
|
2,185,360
|
| Cash and cash equivalents, end of period |
596,858,298
|
663,557
|
3,783,449
|
| Non-cash investing activities |
|
|
|
| Accrual for purchase of plant and equipment |
2,074,681
|
0
|
0
|
| Non cash purchase of plant and equipment |
2,084,235
|
0
|
0
|
| Non-cash financing activities |
|
|
|
| Equity issued for non-cash costs |
0
|
947,464
|
118,759
|
| Private Shares |
|
|
|
| Financing activities |
|
|
|
| Proceeds from share issuance, net of share issuance costs |
21,620,000
|
6,481,381
|
5,379,860
|
| Public Shares |
|
|
|
| Financing activities |
|
|
|
| Proceeds from share issuance, net of share issuance costs |
$ 525,329,273
|
$ 0
|
$ 0
|